PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Bisabolangelone significantly reduced the length of lesions and inhibited H+/K+-ATPase activity in ethanol and Pylorus ligation models [PMID:19429382]
Flower absolute (APMFAb) induced keratinocyte migration, proliferation, and type IV collagen synthesis in vitro [PMID:34684753]
Root extract (APRE) reduced cell viability and induced apoptosis in SH-SY5Y neuroblastoma cells [PMID:26674967]
Angeliticin B exhibited antioxidant activity in DPPH and ABTS experiments [PMID:38767178]
Aqueous extract significantly lowered serum titers of reaginic antibodies in mice [PMID:7130985]
Evidence summary
PubMed sources
- 1.PMID: 38767178 (2025) — Angeliticin B, a new chromone isolated from Angelica polymorpha Maxim. · Natural product research
- 2.PMID: 30875988 (2019) — Sequencing and Comparative Analysis of the Chloroplast Genome of Angelica polymorpha and the Development of a Novel Indel Marker for Species Identification. · Molecules (Basel, Switzerland)
- 3.PMID: 26674967 (2016) — Angelica polymorpha Maxim Induces Apoptosis of Human SH-SY5Y Neuroblastoma Cells by Regulating an Intrinsic Caspase Pathway. · Molecules and cells
- 4.PMID: 34684753 (2021) — Wound Healing-Promoting and Melanogenesis-Inhibiting Activities of Angelica polymorpha Maxim. Flower Absolute In Vitro and Its Chemical Composition. · Molecules (Basel, Switzerland)
- 5.PMID: 19429382